Teva Pharmaceuticals and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the randomised Phase IIb RELIEVE UCCD trial of human ...

but a US appeals court in 2020 reinstated the $235 million judgment against the generics manufacturer. Fast forward to February of this year, and the US Court of Appeals declined Teva's request to ...

Below, FN has compiled some of Teva's most iconic brand collaborations from the past few years. In 2015, Teva collaborated with Opening Ceremony on colorful iterations of three of the brand's ...

Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...

Teva Pharmaceutical is one of the leading global ... halt production and meaningfully hurt the firm's top line as well as brand reputation. However, we don't see this as a likely scenario.

On January 10, 2025, Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing agreement to commercialize EPYSQLI® (eculizumab-aagh), Samsung ...